Risk of Tuberculosis Is Higher With Anti-Tumor Necrosis Factor Monoclonal Antibody Therapy Than With Soluble Tumor Necrosis Factor Receptor Therapy The Three-Year Prospective French Research Axed on Tolerance of Biotherapies Registry
- Publication date
- 1 July 2009
- Publisher
- 'Royal College of Obstetricians & Gynaecologists (RCOG)'